4/A//SEC Filing
D'Andrea Carrie 4/A
Accession 0000950170-24-057822
CIK 0001444192other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:11 PM ET
Size
5.5 KB
Accession
0000950170-24-057822
Insider Transaction Report
Form 4/AAmended
D'Andrea Carrie
VP Clinical Operations
Transactions
- Award
Stock Options (Right to Buy)
2024-05-06+19,740→ 19,740 totalExercise: $2.96Exp: 2034-05-06→ Class A Common Shares (19,740 underlying)
Footnotes (2)
- [F1]This amendment to Form 4 is being filed to amend the signature block in the original Form 4, filed on May 8, 2024, to reflect the correct signatory.
- [F2]Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.
Documents
Issuer
Acasti Pharma Inc.
CIK 0001444192
Entity typeother
Related Parties
1- filerCIK 0001977969
Filing Metadata
- Form type
- 4/A
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:11 PM ET
- Size
- 5.5 KB